Posted on June 8, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Leave a Comment
The U.S. Food and Drug Administration announced today that Clarcon Biological Chemistry Laboratory Inc. of Roy, Utah, is voluntarily recalling some skin sanitizers and skin protectants marketed under several different brand names because of high levels of disease-causing bacteria found in the product during a recent inspection. The FDA is warning consumers to not use any Clarcon products.
Posted on June 3, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
CONCORD, NEW HAMPSHIRE: Thomas Lavery, of Irvine, CA, was sentenced to 52 months of incarceration to be followed by three years of supervised release for illegally distributing large quantities of Serostim, an HIV drug, which were illegally purchased from illegitimate sources and then illegally sold to wholesale distributors in various parts of the country, using falsified paperwork. Judge McAuliffe also entered an order of forfeiture against Lavery for the sum of $1,009,460.
Posted on June 3, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
The U.S. Food and Drug Administration today warned health care professionals about the risk of serious liver injury associated with the use of the anti-thyroid drug propylthiouracil (PTU) for the treatment of Graves’ disease.
Posted on June 3, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
The U.S. Food and Drug Administration today announced the approval of Palladia (toceranib phosphate), the first drug developed specifically for the treatment of cancer in dogs.
Posted on June 2, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
The U.S. Food and Drug Administration recently enhanced its food and feed protection initiatives with the award of three one-year Food Safety and Security Monitoring grants totaling $1 million to the states of Arkansas, Nebraska, and Wisconsin. The funds support cooperative agreements designed to create a national integrated food safety system through enhanced federal and state collaboration in food emergency response activities.
Posted on June 2, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
The U.S. Food and Drug Administration (FDA) today announced the formation of a task force to develop recommendations for enhancing the transparency of the agency’s operations and decision-making process.
Posted on May 31, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) today announced important strides in the understanding of the genetic basis for drug-induced liver injury.
Posted on May 29, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
Richard Pazdur, M.D., a noted oncologist at the U.S. Food and Drug Administration, is being recognized today by the world’s largest cancer professional society.
Posted on May 28, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
The U.S. Food and Drug Administration approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
Posted on May 28, 2009
Filed Under Drugs/Medical Devices, General Information/Questions | Comments Off
The U.S. Food and Drug Administration today approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.